Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report) saw unusually-high trading volume on Tuesday . 20,000 shares were traded during trading, an increase of 176% from the previous session’s volume of 7,258 shares.The stock last traded at $7.93 and had previously closed at $7.99.
Oxford BioMedica Stock Performance
The stock has a 50 day moving average of $8.11 and a 200-day moving average of $8.95.
Oxford BioMedica Company Profile
Oxford BioMedica is a clinical-stage gene and cell therapy company headquartered in Oxford, United Kingdom. The company specializes in the development, manufacturing and commercialization of lentiviral vector delivery systems for use in treating serious diseases. Its proprietary LentiVector® platform underpins both in-house development programs and third-party collaborations, enabling the stable integration of therapeutic genes into target cells.
In its research pipeline, Oxford BioMedica is advancing candidates across ophthalmology, neuroscience and oncology indications.
See Also
- Five stocks we like better than Oxford BioMedica
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
- Industrial and Utility Giants Boost Dividends as Data Center Tailwinds Build
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
